News

EU-X-CT: Borders Should No Longer Be Barriers In Clinical Trials

Published on: 29 August 2024
Member News
Hospitals
Sort Hvid Enkel Citat Instagram Opslag (1) - Lisbeth Snede

For many patients, participating in a clinical trial is a vital lifeline. Lack of of clinical trial options in their home country urges many patients, particularly those with life-threatening or rare diseases, to seek options across borders.

Yet, despite high demand, it is rare for patients to gain access to a clinical trials beyond their home country. The lack of an EU-wide legal framework or any guidance that defines the conditions for accessing clinical trials in another country creates high barriers for patients and healthcare professionals.

It's time to shift the focus from barriers to options.

The EU Cross-Border Clinical Trials Initiative

EU-X-CT is a multi-stakeholder initiative aimed at systematically collecting information on the barriers to cross-border participation in clinical trials from all European countries -inside and outside the EU- and developing recommendations for enabling better access.

The initiative is a concerted effort by volunteers from patient organisations, academics, research networks, industry, and not-for-profit organisations, led by EFGCP and EFPIA.

Watch the video to learn more: Click Here

Discover more about Patients Unite:

Patients Unite is a patient and carer advocate to promote understanding and establish the foundation for successful partnerships in critical areas such as early clinical development, research and the creation of innovative products and services.

 

For healthcare professionals, stakeholders and medical industry professionals immersed in the world of patient management, there is a crucial piece missing – a true understanding of what it means to be a patient. Patients Unite are the valued member of the team that emphasises a philosophy where the patient is not just a participant, but a valued member of your team and project. Patients Unite it’s a movement.

 

The organisation wishes to create a better interaction between stakeholders, healthcare professionals, the pharmaceutical industry and a better network between patient and caregiver advocates.